CANCER ANTIGEN 27.29

  • Item #: Z0599
  * Marked fields are required.
Qty*
Price $59.00
The Food and Drug Administration has approved CA 27.29 for serial
testing in women with prior stage II or III breast cancer who are
clinically free of disease. Increased levels of CA 27.29 (>38 U/mL) may
indicate recurrent disease in a woman with treated breast carcinoma.